Steve Kanters

University of Ottawa

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “The effects of excluding treatments from network meta-analyses: survey”.

The effects of excluding treatments from network meta-analyses: survey

BMJ(2013)10.1136/bmj.f5195

N/A

3.7DataRank · unranked

70 citations

S. Kanters, A.-A. Veroniki, Edward J. Mills, Steve Kanters, Kristian Thorlund +3 more

Antiretroviral therapy for initial human immunodeficiency virus/AIDS treatment: critical appraisal of the evidence from over 100 randomized trials and 400 systematic reviews and meta-analyses

Clinical Microbiology and Infection(2014)10.1111/1469-0691.12475

N/A

1.8DataRank · unranked

25 citations

Steve Kanters, Edward J. Mills, Kristian Thorlund, Heiner C. Bucher, John P. A. Ioannidis +1 more

Comparative efficacy and safety of dabrafenib in combination with trametinib versus competing adjuvant therapies for high-risk melanoma

Journal of Comparative Effectiveness Research(2019)10.2217/cer-2019-0061

N/A

0.396DataRank · unranked

13 citations

Roy Koruth, Steve Kanters, Eric Druyts, Ahmad Tarhini, Rohini Sharma